+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Plantibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Plantibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Plantibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952896
Free Webex Call
10% Free customization
Description Jump to:

Tobacco is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Plantibodies Market, valued at USD 60.91 Million in 2024, is projected to experience a CAGR of 8.18% to reach USD 97.63 Million by 2030. Plantibodies are recombinant antibodies produced in genetically modified plants, designed for diverse therapeutic and diagnostic applications. The market's growth is predominantly supported by the intrinsic advantages of plant-based expression systems, notably lower production costs, superior scalability compared to conventional mammalian cell cultures, and a mitigated risk of contamination from human or animal pathogens. These systems also offer accelerated production timelines due to the rapid growth characteristics of host plants.

Key Market Drivers

The Global Plantibodies Market is primarily driven by cost-effective production and scalability, along with a significantly reduced risk of pathogen contamination. Plant-based expression systems inherently bypass the high capital investments and operational costs associated with traditional mammalian cell cultures, which demand complex sterile bioreactor environments. This allows for scalable cultivation in diverse settings, enabling high-volume biopharmaceutical production at lower per-unit expenses. According to the National Science Foundation's Partnerships for Innovation Research Partnerships (PFI-RP) project, in its 2024 abstract, plant-based biomanufacturing platforms target production exceeding 500 mg per kilogram of plant fresh weight for functional human blood proteins, demonstrating substantial scalability.

Key Market Challenges

The intricate and developing regulatory landscape for plant-derived pharmaceuticals poses a substantial impediment to the growth of the Global Plantibodies Market. The evolving nature of guidelines for genetically modified organisms used in therapeutic production creates uncertainty for developers and investors alike. This complexity often translates into extended timelines for product development and approval, delaying market entry for innovative plantibody candidates.

The compliance burden imposed by diverse and sometimes overlapping regulations significantly increases operational costs for companies engaged in plantibody manufacturing. According to the National Association of Manufacturers, the average manufacturer in the United States incurred over $29,000 per employee per year in federal regulatory compliance costs in 2022, measured in 2023 dollars. This substantial financial overhead, applicable across the manufacturing sector, directly impacts the economic viability of novel plant-based biopharmaceutical ventures.

Key Market Trends

The integration of artificial intelligence into plantibody discovery and optimization is accelerating development timelines and enhancing therapeutic precision. AI algorithms efficiently analyze extensive protein data, predicting optimal modifications for improved binding affinity and efficacy, thereby streamlining initial drug development phases. According to PhRMA, the biopharmaceutical industry invested nearly $101 billion in research and development in 2022, highlighting the sector’s robust commitment to innovation enabling advanced computational methods. For example, Stanford scientists developed a machine learning method achieving a 25-fold improvement in a SARS-CoV-2 antibody by predicting molecular changes, as reported in Science in July 2024. This showcases AI's direct influence on identifying highly effective plantibody variants.

Key Market Players Profiled:

  • PlantForm Corporation
  • Planet Biotechnology Inc.
  • iBio, Inc.
  • Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
  • Medicago Inc.
  • NOMAD Bioscience GmbH
  • Ventria Bioscience Inc.
  • Agrisera AB
  • Creative Biolabs, Inc.
  • Protalix BioTherapeutics Inc.

Report Scope:

In this report, the Global Plantibodies Market has been segmented into the following categories:

By Transgenic Crop:

  • Tobacco
  • Legumes
  • Cereals
  • Seeds & Tubers
  • Fruits & Vegetables
  • Others

By Technique:

  • Conventional Method
  • Tissue Culture
  • Breeding & Sexual Crossing
  • Transgenic Seeds
  • Others

By Application:

  • Autoimmune Diseases
  • Cancer
  • Infectious Diseases
  • Immunization
  • Dentistry
  • Others

By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plantibodies Market .

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Plantibodies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Others)
5.2.2. By Technique (Conventional Method, Tissue Culture, Breeding & Sexual Crossing, Transgenic Seeds, Others)
5.2.3. By Application (Autoimmune Diseases, Cancer, Infectious Diseases, Immunization, Dentistry, Others)
5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Plantibodies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Transgenic Crop
6.2.2. By Technique
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Plantibodies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Transgenic Crop
6.3.1.2.2. By Technique
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Plantibodies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Transgenic Crop
6.3.2.2.2. By Technique
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Plantibodies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Transgenic Crop
6.3.3.2.2. By Technique
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Plantibodies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Transgenic Crop
7.2.2. By Technique
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Plantibodies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Transgenic Crop
7.3.1.2.2. By Technique
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Plantibodies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Transgenic Crop
7.3.2.2.2. By Technique
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Plantibodies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Transgenic Crop
7.3.3.2.2. By Technique
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Plantibodies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Transgenic Crop
7.3.4.2.2. By Technique
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Plantibodies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Transgenic Crop
7.3.5.2.2. By Technique
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Plantibodies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Transgenic Crop
8.2.2. By Technique
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Plantibodies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Transgenic Crop
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Plantibodies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Transgenic Crop
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Plantibodies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Transgenic Crop
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Plantibodies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Transgenic Crop
8.3.4.2.2. By Technique
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Plantibodies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Transgenic Crop
8.3.5.2.2. By Technique
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Plantibodies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Transgenic Crop
9.2.2. By Technique
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Plantibodies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Transgenic Crop
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Plantibodies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Transgenic Crop
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Plantibodies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Transgenic Crop
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Plantibodies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Transgenic Crop
10.2.2. By Technique
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Plantibodies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Transgenic Crop
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Plantibodies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Transgenic Crop
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Plantibodies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Transgenic Crop
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Plantibodies Market : SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. PlantForm Corporation
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Planet Biotechnology Inc.
15.3. iBio, Inc.
15.4. Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
15.5. Medicago Inc.
15.6. NOMAD Bioscience GmbH
15.7. Ventria Bioscience Inc.
15.8. Agrisera AB
15.9. Creative Biolabs, Inc.
15.10. Protalix BioTherapeutics Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Plantibodies market report include:
  • PlantForm Corporation
  • Planet Biotechnology Inc.
  • iBio, Inc.
  • Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
  • Medicago Inc.
  • NOMAD Bioscience GmbH
  • Ventria Bioscience Inc.
  • Agrisera AB
  • Creative Biolabs, Inc.
  • Protalix BioTherapeutics Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 60.91 Million
Forecasted Market Value ( USD ) by 2030 $ 97.63 Million
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Plantibodies - Global Strategic Business Report - Product Image

Plantibodies - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Agricultural Biotechnology for Transgenic Crops Market - Global Forecast 2025-2032 - Product Image

Agricultural Biotechnology for Transgenic Crops Market - Global Forecast 2025-2032

  • Report
  • 199 Pages
  • Global
From
Agricultural Biotechnology - Global Strategic Business Report - Product Image

Agricultural Biotechnology - Global Strategic Business Report

  • Report
  • 263 Pages
  • Global
From
Agricultural Biotechnology Market - Global Forecast 2025-2032 - Product Image

Agricultural Biotechnology Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Agricultural Biotechnology Global Market Report 2025 - Product Image

Agricultural Biotechnology Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.